Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 165
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05101564 | Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer | ||
| NCT01302444 | Treprostinil Combined With Tadalafil for Pulmonary Hypertension | ||
| NCT06059118 | Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | ||
| NCT01795950 | Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) | ||
| NCT00325403 | FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT02279745 | Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension | ||
| NCT04090866 | Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study | ||
| NCT00911248 | PTC299 for Treatment of Neurofibromatosis Type 2 | ||
| NCT03814317 | Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension | ||
| NCT01746485 | Three Times Daily Dosing of UT-15C | ||
| NCT01767194 | Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma | ||
| NCT03833323 | Implantable System for Remodulin Post-Approval Study | ||
| NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH | ||
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | ||
| NCT01557660 | Inhaled Treprostinil for PAH: Open-label Extension | ||
| NCT01321073 | DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study | ||
| NCT02360345 | Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly | ||
| NCT03180957 | Repurposing Anti-TNF for Treating Dupuytren's Disease | ||
| NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension | ||
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | ||
| NCT02603068 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis | ||
| NCT02279160 | Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension | ||
| NCT06580444 | Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study | ||
| NCT07116681 | Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension | ||
| NCT02583789 | Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon | ||
| NCT05060315 | Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin | ||
| NCT03950739 | Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso | ||
| NCT01273922 | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida | ||
| NCT07037836 | Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia | ||
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | ||
| NCT01477333 | Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® | ||
| NCT03055234 | Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD) | ||
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | ||
| NCT01131845 | The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil | ||
| NCT04827056 | Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study | ||
| NCT04708782 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT00439946 | Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH | ||
| NCT01996254 | Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System | ||
| NCT00494533 | Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension | ||
| NCT00004497 | Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension | ||
| NCT03037580 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction | ||
| NCT04677829 | Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI) | ||
| NCT06425796 | Adiposity and Iron Requirements in Pregnancy | ||
| NCT03367312 | Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI | ||
| NCT05848687 | TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II | ||
| NCT06223009 | Phase 1 Healthy Volunteer Burn Therapy Study | ||
| NCT06450041 | NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial | ||
| NCT00325442 | FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT01043627 | Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) | ||
| NCT04870333 | PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V |
